Smith & Nephew PLC
SN.L- Latest Trade
- trading lower1,120.5GBp
- -12.5
- 1.10%
- As of Mar 29 2023. Values delayed up to 15 minutes
- Today's Range
- 1,112.50 - 1,127.00
- 52 Week Range
- 959.20 - 1,338.50
- Previous Close
- 1,133.00
- Open
- 1,116.50
- Volume
- 1,978,069.00
- 3 Month Average Trading Volume
- 46.48
- Shares Out (Mil)
- 873.36
- Market Cap
- 9,850.18
- Forward P/E
- 17.07
- Dividend Yield
- 2.83
Key Statistics
2.38 mean rating - 16 analysts
- P/E Excl. Extra Items (TTM)
- 54.64
- Price To Sales (TTM)
- 2.33
- Price To Book (Quarterly)
- 2.30
- Price To Cash Flow (Per Share TTM)
- 14.47
- Total Debt/Total Equity (Quarterly)
- 54.61
- Long Term Debt/Equity (Quarterly)
- 51.57
- Return On Investment (TTM)
- 2.62
- Return On Equity (TTM)
- 2.14
2021 (millions USD)
About Smith & Nephew PLC (SN.L)
Company Information
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Address
Building 5, Croxley Park, Hatters LaneWATFORD,
WD18 8YE
United Kingdom
Industry
Medical Equipment & Supplies
Executive Leadership
- Roberto Quarta
- Non-Executive Independent Chairman of the Board
- Deepak S. Nath
- Chief Executive Officer, Executive Director
- Anne-Francoise Michele Nesmes
- Chief Financial Officer, Executive Director
- Brad Cannon
- President Orthopaedics, Sports Medicine & ENT and Americas
- Paul Connolly
- President - Global Operations
- Myra Eskes
- President APAC Region and Global Service
- Simon Fraser
- President - Advanced Wound Management and Global Commercial Operations
- Vasant Padmanabhan
- President - Research and Development
- Elga Lohler
- Chief Human Resource Officer
- Alison Parkes
- Chief Compliance Officer
- Helen Barraclough
- Group General Counsel, Company Secretary
- Phil Cowdy
- Chief Corporate Development and Corporate Affairs Office
- Mizanu Kebede
- Chief Quality and Regulatory Affairs Office
- Erik Engstrom
- Non-Executive Independent Director
- Jo Hallas
- Non-Executive Independent Director
- John Ma
- Non-Executive Independent Director
- Katarzyna Mazurhofsaess
- Non-Executive Independent Director
- Rick Medlock
- Non-Executive Independent Director
- Marc E. Owen
- Senior Non-Executive Independent Director
- Angie Risley
- Non-Executive Independent Director
- Bob White
- Non-Executive Independent Director
Latest News
- WorldSmith+Nephew names ex-Serco Group CEO Rupert Soames as chair designate
British medical products maker Smith+Nephew has named Rupert Soames as chairman designate, succeeding Roberto Quarta when he retires this year.
- BusinessUK's Smith+Nephew shares dive 10% after profit margin warning
British medical products maker Smith+Nephew on Thursday warned of lower annual profit margin, weighed by surging inflation and supply chain challenges, sending its shares down 10% to their lowest since March 2020.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,972.40 | -- |
| Copper | 785.65 | 0.31% |
| Brent Crude Oil | 78.14 | 0.65% |
| CBOT Soybeans | 1,475.50 | 0.53% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,027.81 | 1.42% |
| Euro STOXX 50 | 4,231.27 | 1.51% |
| FTSE 100 | 7,564.27 | 1.07% |
| Nikkei 225 | 27,883.78 | 1.33% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes